Back
EHRA Premium Access

Potential for delayed improvement of left ventricular ejection fraction in newly diagnosed heart failure under optimized therapy depends on etiology - data from the PROLONG-II study

Session: ePosters Day 1
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Doctor J. Mueller-Leisse (Hannover, DE)
Event: EHRA 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Johanna Mueller-Leisse

Hannover Heart Rhythm Center, Hannover (Germany)
0 follower

128 more presentations in this session

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

Speaker: Mr M. Van Schie (Rotterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Atrial high-rate episodes in patients with devices without a history of atrial fibrillation

Speaker: Doctor I. Doundoulakis (Brussels, BE)

Access
Abstract
Slides
Like
Thumbnail

The impact of different fat depots in the body on the progression of atrial fibrillation - data from RACE V

Speaker: Doctor V. Weberndoerfer (Maastricht, NL)

Access
Abstract
Slides
Like
Thumbnail

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

Speaker: Mr T. Kueffer (Bern, CH)

Access
Abstract
Slides
Like
Thumbnail

Early mortality and complications following first-time catheter ablation of atrial fibrillation in a nationwide cohort

Speaker: Doctor C. Witt (Aarhus, DK)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePosters Day 1

Speakers: Doctor J. Mueller-Leisse, Mr M. Van Schie, Doctor I. Doundoulakis, Doctor V. Weberndoerfer, Mr T. Kueffer...
Access
Like
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources